"Optimal" cytoreduction for advanced epithelial ovarian cancer: a commentary.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Gynecologic Oncology

• Publication date

  2006-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.YGYNO.2006.07.004PMID 16876853
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Splenectomy in the context of primary cytoreductive operations for advanced epithelial ovarian cancer.

  2006cited by this paper
• What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)

  2006cited by this paper
• Aspirin for the Primary Prevention of Cardiovascular Events in Women and Men: A Sex-Specific Meta-Analysis of Randomized Controlled Trials

  2006cited by this paper
• Aggressive Surgical Effort and Improved Survival in Advanced-Stage Ovarian Cancer

  2006cited by this paper
• The feasibility and morbidity of distal pancreatectomy in extensive cytoreductive surgery for advanced epithelial ovarian cancer

  2005cited by this paper
• Division of pedicles by stapling during cytoreductive surgery for ovarian cancer.

  2005cited by this paper
• Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer.

  2005cited by this paper
• Full-thickness diaphragmatic resection with simple and secure closure to accomplish complete cytoreductive surgery for patients with ovarian cancer.

  2004cited by this paper
• Diaphragm resection for ovarian cancer: technique and short-term complications.

  2004cited by this paper
• Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach.

  2004cited by this paper
• Morbidity of cytoreductive surgery in the elderly.

  2004cited by this paper
• A MULTICENTER STUDY OF CA 125 LEVEL AS A PREDICTOR OF NON-OPTIMAL PRIMARY CYTOREDUCTION OF ADVANCED EPITHELIAL OVARIAN CANCER

  2004cited by this paper
• Morbidity of Cytoreductive Surgery in the Elderly

  2003cited by this paper
• Regional blood flow occlusion during extensive pelvic procedures for ovarian cancer: a randomized trial

  2003cited by this paper
• Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study.

  2003cited by this paper
• Future directions in the surgical management of ovarian cancer.

  2003cited by this paper
• Phase III randomized trial of 12 versus 3 months of maintenance paclitaxel in patients with advanced ovarian cancer after complete response to platinum and paclitaxel-based chemotherapy: a Southwest Oncology Group and Gynecologic Oncology Group trial.

  2003cited by this paper
• Influence of surgery and postoperative therapy and tumor characteristics on patient prognosis in advanced ovarian carcinomas.

  2003cited by this paper
• Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study.

  2003cited by this paper
• Intraperitoneal chemotherapy for ovarian carcinoma: results of long-term follow-up.

  2002cited by this paper
• Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis.

  2002cited by this paper
• The effect of bowel resection on survival in advanced epithelial ovarian cancer.

  2001cited by this paper
• Procedures required to accomplish complete cytoreduction of ovarian cancer: is there a correlation with "biological aggressiveness" and survival?

  2001cited by this paper
• Identification of prognostic factors in advanced epithelial ovarian carcinoma.

  2001cited by this paper
• Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Gr

  2001cited by this paper
• Safety and efficacy of low anterior en bloc resection as part of cytoreductive surgery for patients with ovarian cancer.

  2001cited by this paper
• What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial ovarian cancer?

  2001cited by this paper
• A critique of surgical cytoreduction in advanced ovarian cancer.

  2000cited by this paper
• The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma.

  2000cited by this paper
• Complete cytoreduction: is epithelial ovarian cancer confined to the pelvis biologically different from bulky abdominal disease?

  2000cited by this paper
• Primary cytoreductive surgery with rectosigmoid colon resection for patients with advanced epithelial ovarian carcinoma

  2000cited by this paper
• The problems of surgical training in gynaecologic oncology.

  2000cited by this paper
• Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study.

  1998cited by this paper
• Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients.

  1998cited by this paper
• Does debulking surgery improve survival in biologically aggressive ovarian carcinoma?

  1997cited by this paper
• Extensive cytoreductive surgery in advanced ovarian carcinoma.

  1997cited by this paper
• Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer.

  1996cited by this paper
• Ultraradical debulking of epithelial ovarian cancer with the ultrasonic surgical aspirator: a prospective randomized trial.

  1996cited by this paper
• Webster's New World Dictionary and Thesaurus

  1996cited by this paper
• The prognostic significance of residual disease, FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancer.

  1995cited by this paper
• Splenectomy as part of cytoreductive surgery for ovarian carcinoma.

  1995cited by this paper
• Loop electrosurgical excision procedure for intensified cytoreduction of ovarian cancer.

  1995cited by this paper
• Extensive primary cytoreductive surgery for advanced epithelial ovarian cancer.

  1994cited by this paper
• The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma.

  1994cited by this paper
• Reproducibility of tumor measurements in ovarian cancer: a study of interobserver variability.

  1994cited by this paper
• Long term survival by cytoreductive surgery to less than 1 cm, induction weekly cisplatin and monthly cisplatin, doxorubicin, and cyclophosphaide therapy in advanced ovarian adenocarcinoma

  1994cited by this paper
• The influence of tumor grade, distribution, and extent of carcinomatosis in minimal residual stage III epithelial ovarian cancer after optimal primary cytoreductive surgery.

  1994cited by this paper
• Peritoneal implant elimination during cytoreductive surgery for ovarian cancer: impact on survival.

  1993cited by this paper
• The impact of subspecialty training on the management of advanced ovarian cancer.

  1992cited by this paper
• Endometrial adenocarcinoma: genetic analysis suggesting heritable site-specific uterine cancer.

  1992cited by this paper
• The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study.

  1992cited by this paper
• The cavitational ultrasonic surgical aspirator for cytoreduction in advanced ovarian cancer

  1992cited by this paper
• Modified posterior exenteration for ovarian cancer.

  1991cited by this paper
• Primary surgical therapy of ovarian cancer: how much and when.

  1990cited by this paper
• Resection of diaphragmatic peritoneum and muscle: role in cytoreductive surgery for ovarian cancer

  1990cited by this paper
• Direct diffusion of cis-diamminedichloroplatinum(II) in intraperitoneal rat tumors after intraperitoneal chemotherapy: a comparison with systemic chemotherapy.

  1989cited by this paper
• Resection of diaphragmatic peritoneum and muscle: role in cytoreductive surgery for ovarian cancer

  1989cited by this paper
• Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: a Gynecologic Oncology Group Study.

  1989cited by this paper
• The impact of aggressive debulking surgery and cisplatin-based chemotherapy on progression-free survival in stage III and IV ovarian carcinoma.

  1988cited by this paper
• Outcome of primary cytoreduction surgery for advanced epithelial ovarian carcinoma.

  1988cited by this paper
• Primary Cytoreductive Surgery for Epithelial Ovarian Cancer

  1983cited by this paper
• Surgery for common epithelial tumors of the ovary

  1981cited by this paper
• A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate.

  1979cited by this paper
• A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate.

  1979cited by this paper
• Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma.

  1975cited by this paper
• Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma.

  1975cited by this paper

• Peritonectomy and resection of mesentery during Visceral-Peritoneal Debulking (VPD) in patients with stage IIIC-IV ovarian cancer: A phase I-II trial.

  2024cites this paper
• Prediction of the survival of patients with advanced‐stage ovarian cancer patients undergoing interval cytoreduction with the use of computed tomography reevaluation after neoadjuvant chemotherapy

  2023cites this paper
• Importance of Laparoscopy in Predicting Complete Cytoreduction at Advanced Stage Ovarian Cancer

  2022cites this paper
• Residual Microscopic Peritoneal Metastases after Macroscopic Complete Cytoreductive Surgery for Advanced High-Grade Serous Ovarian Carcinoma: A Target for Folate Receptor Targeted Photodynamic Therapy?

  2022cites this paper
• Cytoreductive or debulking surgery in ovarian cancer: The name does matter!

  2021cites this paper
• Quaternary and beyond cytoreduction: An updated and expanded analysis

  2021cites this paper
• The Philippine Journal of GYNECOLOGIC ONCOLOGY

  2020cites this paper
• Microscopic Peritoneal Residual Disease after Complete Macroscopic Cytoreductive Surgery for Advanced High Grade Serous Ovarian Cancer

  2020cites this paper
• Synthèse et caractérisation de nanoparticules magnétiques répondantes pour des applications en thérapie cancéreuse

  2020cites this paper
• Frontline Management of Epithelial Ovarian Cancer—Combining Clinical Expertise with Community Practice Collaboration and Cutting-Edge Research

  2020cites this paper
• The Fundamental Role of Postoperative Critical Care in Gynecologic Oncology Surgery: A Brief Report

  2020influential citation
• An overview and update of hyperthermic intraperitoneal chemotherapy in ovarian cancer

  2020cites this paper
• Elevated Glutaminase in Epithelial Ovarian Cancer Patients Increased the Suboptimal Cytoreduction

  2019cites this paper
• High Expression of HLA-G in Ovarian Carcinomatosis: The Role of Interleukin-1β

  2019cites this paper
• Correlation of Pattern of Spread and Outcomes in Advanced Epithelial Ovarian Cancers

  2018cites this paper
• Clinical Outcome After Completion Surgery in Patients With Ovarian Cancer: The Charite Experience

  2018cites this paper
• Laparoscopy for primary cytoreduction with multivisceral resections in advanced ovarian cancer: prospective validation. “The times they are a-changin”?

  2018cites this paper
• Pathology of Female Cancers

  2018influential citation
• Bevacizumab Does Not Reduce the Lymphocele Rate in Advanced Ovarian Cancer After Complete Cytoreductive Surgery.

  2018cites this paper
• Current Concept of Precancerous and Early Stage of Serous Ovarian Carcinoma

  2018cites this paper
• Outcome of Bowel Resection in Women with Advanced Ovarian Carcinoma

  2018cites this paper
• Prognostic Factors in Patients Undergoing Primary Cytoreductive Surgery for FIGO Stage IIIC Ovarian, Tubal or Peritoneal Cancer.

  2017cites this paper
• Patterns and Prognostic Importance of Hepatic Involvement in Patients with Serous Ovarian Cancer: A Single-Institution Experience with 244 Patients.

  2017cites this paper
• Traitement des métastases péritonéales des cancers épithéliaux de l’ovaire par thérapie photodynamique. Limites et perspectives

  2017cites this paper
• F-18 FDG PET/CT metabolic tumor volume predicts overall survival in patients with disseminated epithelial ovarian cancer.

  2017cites this paper
• [Specific folic-acid targeted photosensitizer. The first step toward intraperitoneal photodynamic therapy for epithelial ovarian cancer].

  2017cites this paper
• Prognostic value of miliary versus non-miliary sub-staging in advanced ovarian cancer.

  2017cites this paper
• [Intraperitoneal photodynamic therapy for peritoneal metastasis of epithelial ovarian cancer. Limits and future prospects].

  2017cites this paper
• Do critical care units play a role in the management of gynaecological oncology patients? The contribution of gynaecologic oncologist in running critical care units.

  2017cites this paper
• Dealing with microscopic peritoneal metastases of epithelial ovarian cancer. A surgical challenge.

  2017cites this paper
• Evaluation of urgent multivisceral resections due to complications resulting from an advanced ovarian cancer.

  2016cites this paper
• Assessment of the specificity of a new folate-targeted photosensitizer for peritoneal metastasis of epithelial ovarian cancer to enable intraperitoneal photodynamic therapy. A preclinical study.

  2016cites this paper
• Single-port or Classic Laparoscopy Compared With Laparotomy to Assess the Peritoneal Cancer Index in Primary Advanced Epithelial Ovarian Cancer.

  2016cites this paper
• UNIVERSITÀ DEGLI STUDI DI MILANO SCUOLA DI DOTTORATO IN MEDICINA MOLECOLARE CICLO XXVIII Anno Accademico 2014/2015 TESI DI DOTTORATO DI RICERCA BIO/10 NON-CODING RNAs IN HIGH-GRADE SEROUS EPITHELIAL OVARIAN CANCER Dottoranda:

  2016cites this paper
• Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treatment of ovarian cancer

  2016cites this paper
• Results of optimal debulking surgery with bowel resection in patients with advanced ovarian cancer

  2016cites this paper
• Traitement des métastases péritonéales microscopiques des cancers épithéliaux de l'ovaire par thérapie photodynamique ciblée utilisant un adressage par acide folique. Données précliniques

  2016cites this paper
• Impact du bevacizumab adjuvant sur les lymphocèles dans les tumeurs épithéliales malignes de l’ovaire de stade avancé

  2015cites this paper
• Peritoneal Carcinomatosis from Ovarian Cancer

  2015cites this paper
• Partial resection of the sixth segment of the liver in a young woman with recurrent ovarian cancer – case report

  2015cites this paper
• Fischer 344 Rat: A Preclinical Model for Epithelial Ovarian Cancer Folate-Targeted Therapy

  2015cites this paper
• Overview of Gynecologic Cancers

  2015cites this paper
• Synthèse de systèmes à base de photosensibilisateurs pour l'amélioration de la sélectivité tumorale en thérapie photodynamique

  2015cites this paper
• Diagnosis and Management of Epithelial Ovarian Cancer with Peritoneal Metastases

  2014cites this paper
• [FRα: a target for prophylactic photodynamic therapy of ovarian peritoneal metastasis?].

  2014cites this paper
• Prognostic role of bowel involvement in optimally cytoreduced advanced ovarian cancer: a retrospective study

  2014cites this paper
• Progress in Survival Outcomes in Patients with Advanced Ovarian Cancer Treated by Neo-Adjuvant Platinum/Taxane-Based Chemotherapy and Late Interval Debulking Surgery

  2014cites this paper
• En-bloc pelvic resection with concomitant rectosigmoid colectomy and immediate anastomosis as part of primary cytoreductive surgery for patients with advanced ovarian cancer.

  2014cites this paper
• Treatment of Ovarian Anaplastic Ependymoma by an Aromatase Inhibitor

  2014cites this paper
• Abdominal Aortic Resection and Y-Graft Placement to Achieve Complete Cytoreduction in Stage IIIc Ovarian Carcinoma

  2014cites this paper
• Częściowa resekcja szóstego segmentu wątroby u młodej kobiety ze wznową pierwotnie zaawansowanego raka jajnika – opis przypadku

  2014cites this paper
• Advanced ovarian cancer: what should be the standard of care?

  2013cites this paper
• Cáncer de ovario avanzado (Etapa clínica IIIc). Resultados del tratamiento quirúrgico en 100 pacientes

  2013cites this paper
• Advanced ovarian cancer (Clinical stage IIIC). Results of surgical treatment in 100 patients

  2013cites this paper
• Outcomes in Ovarian Cancer among Hispanic Women Living in the United States: A Population-Based Analysis

  2013cites this paper
• Overview of Palliative Surgery: Principles and Priorities

  2012cites this paper
• Comparison of Morbidity and Survival Between Primary and Interval Cytoreductive Surgery in Patients After Modified Posterior Pelvic Exenteration for Advanced Ovarian Cancer

  2012cites this paper
• Surgical management of recurrent ovarian cancer

  2012cites this paper
• Preoperative [18F]FDG PET/CT predicts recurrence in patients with epithelial ovarian cancer

  2012cites this paper
• Initial surgical management of ovarian cancer

  2012cites this paper
• Hyperthermic intraperitoneal chemotherapy in ovarian cancer: rationale and clinical data

  2012cites this paper
• Photodiagnosis and photodynamic therapy of peritoneal metastasis of ovarian cancer.

  2012cites this paper
• PET/CT in gynecologic cancer: present applications and future prospects--a clinician's perspective.

  2011cites this paper
• Neoadjuvant chemotherapy for advanced ovarian cancer: overview of outcomes and unanswered questions

  2011cites this paper
• [Complications of radical surgery for advanced ovarian cancer].

  2011cites this paper
• Implications of upper abdominal disease in advanced ovarian cancer after surgical cytoreduction and relation with tumor biology.

  2011cites this paper
• Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: multi-institutional phase-II trial.

  2011cites this paper
• Complications de la chirurgie radicale des cancers de l’ovaire de stade avancé

  2011cites this paper
• Place de la chirurgie d’intervalle dans le traitement du cancer avancé de l’ovaire

  2011cites this paper
• Tumor associated mesenchymal stem cells protects ovarian cancer cells from hyperthermia through CXCL12

  2011cites this paper
• The impact of disease distribution on survival in patients with stage III epithelial ovarian cancer cytoreduced to microscopic residual: a Gynecologic Oncology Group study.

  2011cites this paper
• Is hysterectomy needed in ovarian cancer?

  2011cites this paper
• PROGNOSTIC FACTORS IN EPITHELIAL OVARIAN CARCINOMA: A REFERENCE INSTITUTION EXPERIENCE

  2011cites this paper
• Morbidity of diaphragmatic surgery for advanced ovarian cancer: retrospective study of 148 cases.

  2011cites this paper
• How to improve the optimal cytoreductive surgery in advanced ovarian carcinoma

  2011cites this paper
• To predict or not to predict? The dilemma of predicting the risk of suboptimal cytoreduction in ovarian cancer.

  2011cites this paper
• Platinum-based adjuvant chemotherapy on moderate- and high-risk stage I and II epithelian ovarian cancer patients. Long-term single institution experience and literature review

  2011cites this paper
• [The role of interval surgery in the treatment's strategy of advanced ovarian cancer].

  2011cites this paper
• Hyperthermic intraperitoneal chemotherapy ( HIPEC ) in optimally cytoreduced peritoneal carcinomatosis of gynecology origin : Does it provide survival advantage ?

  2010cites this paper
• PET/CT in Gynecologic Cancer: Present Applications and Future Prospects-A Clinician's Perspective.

  2010cites this paper
• Does the use of diagnostic PET/CT cause stage migration in patients with primary advanced ovarian cancer?

  2010cites this paper
• 23. Ovarian Cancer

  2010cites this paper
• Current Chemotherapy of Ovarian Cancer

  2010cites this paper
• Centralized treatment of advanced stages of ovarian cancer improves survival: a nationwide Danish survey

  2010cites this paper
• Centralization of ovarian cancer surgery: do patients benefit?

  2010cites this paper
• Multicellular spheroids in ovarian cancer metastases: Biology and pathology.

  2009cites this paper
• Aggressive surgical strategies in advanced ovarian cancer: a monocentric study of 203 stage IIIC and IV patients.

  2009cites this paper
• In Pursuit of Optimal Cytoreduction in Ovarian Cancer Patients: The Role of Surgery and Surgeon.

  2009cites this paper
• Management of women with newly diagnosed ovarian cancer.

  2009cites this paper
• Cytoreductive surgery and modified heated intraoperative intraperitoneal chemotherapy (HIPEC) for advanced and recurrent ovarian cancer -- 12-year single center experience.

  2009cites this paper
• Surgical Management of the Subdiaphragmatic Mass: A Sequential Combined Approach With Laparoscopy Followed by Posterior Thoracotomy

  2009cites this paper
• Ovarian cancer

  2009cites this paper
• Intra‐abdominal tumor dissemination pattern and surgical outcome in 214 patients with primary ovarian cancer

  2009cites this paper
• Surveillance of patients after initial treatment of ovarian cancer.

  2009cites this paper
• Trials With Impact on Clinical Management: First Line

  2009cites this paper
• [Towards a new standard in cytoreductive surgery for advanced ovarian cancer].

  2009cites this paper
• When Should Surgical Cytoreduction in Advanced Ovarian Cancer Take Place?

  2009cites this paper
• Predicting the Outcome of Cytoreductive Surgery for Advanced Ovarian Cancer: A Review

  2009cites this paper
• Perspectives in the Management of Ovarian Cancer

  2009cites this paper
• Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial

  2009cites this paper